p-Toluenesulfonic acid monohydrate → HCID 178433271, Verbindung

HRID 2080992Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 2080992
[Cl:1][C:2]1[C:7]([F:8])=[C:6]([F:9])[CH:5]=[CH:4][C:3]=1[CH2:10][NH:11][C:12]([CH:14]1[CH2:18][NH:17][C:16](=[O:19])[N:15]1[CH3:20])=[O:13].Cl.[CH3:22][C:23]1[N:24]=[CH:25][NH:26][C:27]=1[CH2:28]O.O.C1(C)C=CC(S(O)(=O)=O)=CC=1>CN1CCCC1=O.ClCCl>[Cl:1][C:2]1[C:7]([F:8])=[C:6]([F:9])[CH:5]=[CH:4][C:3]=1[CH2:10][NH:11][C:12]([CH:14]1[CH2:18][N:17]([CH2:28][C:27]2[NH:26][CH:25]=[N:24][C:23]=2[CH3:22])[C:16](=[O:19])[N:15]1[CH3:20])=[O:13]

Komponenten

6

Versuchsvorschrift

A solution of N-[(2-chloro-3,4-difluorophenyl)methyl]-3-methyl-2-oxo-4-imidazolidinecarboxamide (152 mg, 0.5 mmol) (prepared as described in Example 28), (4-methyl-1H-imidazol-5-yl)methanol hydrochloride (93 mg, 0.625 mmol) and p-toluene sulfonic acid monohydrate (19 mg, 0.100 mmol) in N-methyl-2-pyrrolidone (1 ml) was heated at 130° C. under argon for 3 h. The reaction mixture was cooled to room temperature and diluted with dichloromethane. The solution was washed with saturated sodium hydrogen carbonate solution and brine, dried and evaporated. The residue was purified by mass-directed automated HPLC, followed by trituration with ether to give N-[(2-chloro-3,4-difluorophenyl)methyl]-3-methyl-1-[(4-methyl-1H-imidazol-5-yl)methyl]-2-oxo-4-imidazolidinecarboxamide (147 mg, 74%). LC/MS [M+H]+=398, retention time=1.57 minutes.

Aufarbeitung

  1. washThe solution was washed with saturated sodium hydrogen carbonate solution and brine
  2. customdried
  3. customevaporated
  4. customThe residue was purified

Quellen und Nachweise

ORD-Eintrag
ord-07145fe5a9d647ceb0743b1767052f77
Quelldatensatz
uspto-grants-2011_04
Patentnummer
US07932282B2

Notizen zur Reaktion

Wird geladen…